Khiron Life Sciences Statistics
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
KHRNF has 232.41 million shares outstanding.
Current Share Class | 232.41M |
Shares Outstanding | 232.41M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +15.06% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 0.22% |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.00 |
PB Ratio | 0.00 |
P/TBV Ratio | 0.00 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.02, with a Debt / Equity ratio of 0.09.
Current Ratio | 2.02 |
Quick Ratio | 0.71 |
Debt / Equity | 0.09 |
Debt / EBITDA | n/a |
Debt / FCF | -0.15 |
Interest Coverage | -39.01 |
Financial Efficiency
Return on equity (ROE) is -74.68% and return on invested capital (ROIC) is -25.17%.
Return on Equity (ROE) | -74.68% |
Return on Assets (ROA) | -20.79% |
Return on Invested Capital (ROIC) | -25.17% |
Return on Capital Employed (ROCE) | -59.33% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.31 |
Inventory Turnover | 0.96 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | 18.84 |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | 0.00 |
Relative Strength Index (RSI) | 43.94 |
Average Volume (20 Days) | 61,015 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KHRNF had revenue of 11.75 million and -22.33 million in losses. Loss per share was -0.12.
Revenue | 11.75M |
Gross Profit | 4.86M |
Operating Income | -12.70M |
Pretax Income | -22.60M |
Net Income | -22.33M |
EBITDA | -11.95M |
EBIT | -12.70M |
Loss Per Share | -0.12 |
Balance Sheet
The company has 1.41 million in cash and 1.87 million in debt, giving a net cash position of -455,953 or -0.00 per share.
Cash & Cash Equivalents | 1.41M |
Total Debt | 1.87M |
Net Cash | -455,953 |
Net Cash Per Share | -0.00 |
Equity (Book Value) | 19.74M |
Book Value Per Share | 0.09 |
Working Capital | 6.75M |
Cash Flow
In the last 12 months, operating cash flow was -10.93 million and capital expenditures -1.90 million, giving a free cash flow of -12.83 million.
Operating Cash Flow | -10.93M |
Capital Expenditures | -1.90M |
Free Cash Flow | -12.83M |
FCF Per Share | -0.06 |
Margins
Gross margin is 41.34%, with operating and profit margins of -108.07% and -190.00%.
Gross Margin | 41.34% |
Operating Margin | -108.07% |
Pretax Margin | -192.28% |
Profit Margin | -190.00% |
EBITDA Margin | -101.67% |
EBIT Margin | -108.07% |
FCF Margin | n/a |
Dividends & Yields
KHRNF does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -24.67% |
Shareholder Yield | -24.67% |
Earnings Yield | -9,625,950.00% |
FCF Yield | -5,530,816.38% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
KHRNF has an Altman Z-Score of -3.62. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -3.62 |
Piotroski F-Score | n/a |